Glaukos (GKOS) FCF Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,143.00 |
| Dec 31, 2025 | -1,506.00 |
| Sep 30, 2025 | 1,806.00 |
| Jun 30, 2025 | 3,590.00 |
| Mar 31, 2025 | 725.00 |
| Dec 31, 2024 | 702.00 |
| Sep 30, 2024 | -459.00 |
| Jun 30, 2024 | -2,951.00 |
| Mar 31, 2024 | -3,987.00 |
| Dec 31, 2023 | -2,833.00 |
| Sep 30, 2023 | -661.00 |
| Jun 30, 2023 | -2,443.00 |
| Mar 31, 2023 | -3,180.00 |
| Dec 31, 2022 | -565.00 |
| Sep 30, 2022 | -5,708.00 |
| Jun 30, 2022 | -3,700.00 |
| Mar 31, 2022 | 32.00 |
| Dec 31, 2021 | -7,226.00 |
| Sep 30, 2021 | 5,593.00 |
| Jun 30, 2021 | -4,036.00 |
| Mar 31, 2021 | 618.00 |
| Dec 31, 2020 | 1,621.00 |
| Sep 30, 2020 | -1,284.00 |
| Jun 30, 2020 | -3,853.00 |
| Mar 31, 2020 | -1,804.00 |
| Dec 31, 2019 | 444.00 |
| Sep 30, 2019 | -82.00 |
| Jun 30, 2019 | 988.00 |